Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 811-502-1 | CAS number: 73206-60-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant guideline study, available as unpublished report, no restrictions, fully adequate for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- 4-isobutyl-2-methylbenzaldehyde
- Cas Number:
- 73206-60-7
- Molecular formula:
- C12H16O
- IUPAC Name:
- 4-isobutyl-2-methylbenzaldehyde
- Details on test material:
- - Name of test material (as cited in study report): IBTAL
- Lot No.: 5N24
- Purity: 98.8%
- Description: Colorless and transparence liquid
- Storage conditions: Stored at room temperature (actual temperature: 18.5°C to 20.6°C; permissible range: 1°C to 30°C) in a tight container (filled with nitrogen)
- Expiration date: March 31, 2015
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD(SD)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories Japan, Inc. (Hino Breeding Center)
- Age at study initiation: 9 weeks
- Weight at study initiation: Experiment 1: 190.5 to 202.3 g, Experiment 2: 181.5 to 201.5 g, Experiment 3: 205.1 to 208.3 g, Experiment 4: 206.2 to 209.8 g
- Fasting period before study: the day before administration (about 18.5 to 19.5 hours before dosing) to about 3 hours after dosing.
- Housing: four animals per cage during the quarantine and acclimatization periods, three animals per cage after the grouping, two animals per cage for the remaining animals; in stainless-steel cages on polymethylpentene floors (W × D × H: 220 × 380 × 195 mm); autoclave-sterilized wood chip bedding (White Flake, Charles River Laboratories Japan, Inc.); autoclave-sterilized nest materials (Paper Clean, Japan SLC, Inc.) were used for improvement of animal welfare and exchanged concurrently with the cage exchange.
- Diet: Autoclave-sterilized pellet diet (CRF-1, Oriental Yeast Co., Ltd.), ad libitum
- Water: Well water admixed with sodium hypochlorite (free residual chlorine concentration: about 2 ppm), ad libitum
- Acclimation period: 7 days for experiments 1 and 3, 11 days for experiment 2 and 14 days for experiment 4.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 - 24
- Humidity (%): 45.7 – 63.8
- Air changes (per hr): 10 - 20
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 30 and 200 mg/mL
- Amount of vehicle (if gavage): 10 mL/kg
- Lot/batch no. (if required): V3T2547, NACALAI TESQUE, INC.)
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: Structurally similar analogs to the test substance were categorized as Category 4 or Unclassified of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS). Therefore, the dose level for the experiment 1 was set at 300 mg/kg. The dose levels for the experiments 2 to 4 were respectively set at 300, 2000 and 2000 mg/kg. - Doses:
- - Experiment 1 and 2: 300 mg/kg
- Experiment 3 and 4: 2000 mg/kg - No. of animals per sex per dose:
- 3 per experiment
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: All animals were observed before dosing and 30 minutes, 1, 3 and 5 hours after dosing on the day of administration, and thereafter, once daily for 14 days.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight (All animals were measured before dosing on Day 1 and on Days 2, 4, 8 and 15. In addition, the body weight gain between each day of measurement was calculated.)
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 2 500 mg/kg bw
- Based on:
- test mat.
- Mortality:
- - No deaths occurred in experiment 1, 2 or 3.
- In experiment 4, 1 animal died on Day 2. - Clinical signs:
- - No abnormality was observed in any animal of experiment 1 or 2.
- In the experiment 3, 1 animal showed decrease in locomotor activity (grade: moderate), prone position and bradypnea on Day 2. These findings were not observed on Day 3 and thereafter.
- The animal that died showed abnormalities on Day 1 as follows: decrease in locomotor activity (grade: slight) and bradypnea at 3 hours after dosing and decrease in locomotor activity (grade: moderate), prone position and bradypnea at 5 hours after dosing. In another animal, the following findings were observed: decrease in locomotor activity (grade: slight) at 3 hours after dosing, decrease in locomotor activity (grade: slight) and bradypnea at 5 hours after dosing, and decrease in locomotor activity (grade: slight) on Day 2. No abnormality was observed in the animal on Day 3 and thereafter. - Body weight:
- - A normal body weight increase was noted in all animals of experiments 1 and 2.
- In experiments 3 and 4, a decreased body weight or a suppressed body weight gain was noted in all animals between Day 1 and 2. On Day 4 and thereafter, no abnormality was noted in the body weight gain of any animals. - Gross pathology:
- No abnormality was observed in any animal.
Applicant's summary and conclusion
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The LD50 was estimated to be 2500 mg/kg bw in females.
- Executive summary:
In a GLP compliant acute oral toxicity study, in accordance with OECD Guideline 423 (acute toxic class method), female Crl: CD(SD) rats were exposed to the test substance via oral gavage. The dose levels were respectively set at 300, 300, 2000 and 2000 mg/kg for experiments 1 to 4. Three females were used in each experiment. After an observation period of 14 days animals were necropsied. No death occurred and no abnormality was noted in the clinical observation, body weight or necropsy in any animal of the experiment 1 or 2. One animal died in experiment 4 and abnormalities were noted in the experiments 3 and 4 as follows. In the clinical observation, decrease in locomotor activity, prone position or bradypnea was observed in 1 animal in the experiment 3 and 2 animals in the experiment 4 on Day 1 or 2. In the body weight, a decreased body weight or a suppressed body weight gain was noted in all animals between Day 1 and 2. On Day 3 and thereafter, no abnormality was noted in the clinical observation or body weight. All animals including the dead animal showed no finding in the necropsy. The LD50 was estimated to be 2500 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.